<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04739059</url>
  </required_header>
  <id_info>
    <org_study_id>CSL312_3002</org_study_id>
    <secondary_id>2020-003918-12</secondary_id>
    <nct_id>NCT04739059</nct_id>
  </id_info>
  <brief_title>Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema Attacks</brief_title>
  <official_title>An Open-label Study to Evaluate the Long-term Safety and Efficacy of CSL312 (Garadacimab) in the Prophylactic Treatment of Hereditary Angioedema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CSL Behring</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CSL Behring</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This phase 3b study will evaluate long-term safety and efficacy of CSL312 (also known as&#xD;
      garadacimab) when administered subcutaneously (SC)&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 29, 2021</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of subjects with treatment emergent adverse events (TEAEs)</measure>
    <time_frame>Up to 32 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Percentage of subjects with TEAEs</measure>
    <time_frame>Up to 32 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>TEAEs rates per injection</measure>
    <time_frame>Up to 32 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>TEAEs rates per subject year</measure>
    <time_frame>Up to 32 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The time-normalized number (per month and year) of Hereditary Angioedema (HAE attacks) for the entire study</measure>
    <time_frame>Up to 34 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The percentage reduction and the number of subjects experiencing at least ≥ 50% ≥ 70%, ≥ 90 or equal to 100% (attack free) reduction in the time-normalized number of HAE attacks on Treatment compared to Run-in Period</measure>
    <time_frame>Up to 34 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time-normalized number (per month and year) of HAE attacks requiring on-demand treatment in subjects on treatment</measure>
    <time_frame>Up to 32 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The time-normalized number (per month and year) of moderate and/or severe HAE attacks in subjects on treatment</measure>
    <time_frame>Up to 32 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number and percentage of subjects rating their response to therapy as good or excellent</measure>
    <time_frame>Up to 32 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number and percentage of subjects experiencing TEAEs</measure>
    <time_frame>Up to 32 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number and percentage of subjects experiencing adverse events of special interest (AESIs)</measure>
    <time_frame>Up to 32 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number and percentage of subjects experiencing TEAEs for naïve C1-INH subjects only</measure>
    <time_frame>Up to 32 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number and percentage of subjects experiencing serious adverse events (SAEs), including deaths</measure>
    <time_frame>Up to 32 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The number and percentage of subjects experiencing CSL312 induced anti-CSL312 antibodies</measure>
    <time_frame>Up to 32 months</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Hereditary Angioedema</condition>
  <arm_group>
    <arm_group_label>CSL312</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Fully human immunoglobulin G subclass 4/lambda recombinant monoclonal antibody administered subcutaneously</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>CSL312</intervention_name>
    <description>Fully human immunoglobulin G subclass 4/lambda recombinant monoclonal antibody</description>
    <arm_group_label>CSL312</arm_group_label>
    <other_name>Factor XIIa antagonist monoclonal antibody</other_name>
    <other_name>garadacimab</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Males and females aged ≥ 12 years&#xD;
&#xD;
          -  Diagnosed with clinically confirmed C1-INH HAE&#xD;
&#xD;
          -  Experienced ≥ 3 HAE attacks during the 3 months before Screening&#xD;
&#xD;
          -  Participated in the Run-in Period for at least 1 month (CSL312-naïve subjects only)&#xD;
&#xD;
          -  Experienced at least an average of 1 HAE attack per month during the Run-in Period&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Concomitant diagnosis of another form of angioedema, such as idiopathic or acquired&#xD;
             angioedema or recurrent angioedema associated with urticaria&#xD;
&#xD;
          -  Use of C1-INH products, androgens, antifibrinolytics or other small molecule&#xD;
             medications for routine prophylaxis against HAE attacks at least 2 weeks before the&#xD;
             first day of the Run-in Period&#xD;
&#xD;
          -  Use of monoclonal antibodies such as lanadelumab (Takhzyro®) 3 months before the first&#xD;
             day of the Run-in Period.&#xD;
&#xD;
          -  Female subjects use estrogen-containing oral contraceptives or hormone replacement&#xD;
             therapy within 4 weeks prior to screening&#xD;
&#xD;
          -  Female or male subjects who are fertile and sexually active not using or not willing&#xD;
             to use an acceptable method of contraception to avoid pregnancy during the study and&#xD;
             for 30 days after receipt of the last dose of CSL312&#xD;
&#xD;
          -  Pregnant, breastfeeding, or not willing to cease breastfeeding&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Study Director</last_name>
    <role>Study Director</role>
    <affiliation>CSL Behring</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Trial Registration Coordinator</last_name>
    <phone>610-878-4000</phone>
    <email>clinicaltrials@cslbehring.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Clinical Research Center of Alabama</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35209</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Anderson, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 2052094131</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Research Solutions of Arizona</name>
      <address>
        <city>Litchfield Park</city>
        <state>Arizona</state>
        <zip>85340</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Connie Hsu, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 623.512.4341</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Medical Research of Arizona</name>
      <address>
        <city>Scottsdale</city>
        <state>Arizona</state>
        <zip>85251</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michael Manning, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 480-889-6318</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Little Rock Allergy &amp; Asthma Clinic</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72205</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karl Sitz, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 501 224 1156</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Donald S. Levy M.D.</name>
      <address>
        <city>Orange</city>
        <state>California</state>
        <zip>92868</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donald Levy, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 714-639-7847</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Raffi Tachdjian MD, Inc.</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raffi Tachdjian, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 310 998 0060</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Allergy &amp; Asthma Clinical Research</name>
      <address>
        <city>Walnut Creek</city>
        <state>California</state>
        <zip>94598</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joshua Jacobs, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 925 935-2599</phone>
      <phone_ext>136</phone_ext>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Institute for Asthma and Allergy PC</name>
      <address>
        <city>Chevy Chase</city>
        <state>Maryland</state>
        <zip>20815</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Henry H. Li, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 301-986-9262</phone>
      <phone_ext>211</phone_ext>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Jay Michael Kashkin, MD</name>
      <address>
        <city>Fair Lawn</city>
        <state>New Jersey</state>
        <zip>07410</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jay M. Kashkin, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 201-794-7400</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Bernstein Clinical Research Center, LLC</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jonathan Bernstein, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 513 354-1750</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>AARA Research Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Lumry, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 2143650365</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Campbelltown Hospital / Western Sydney University</name>
      <address>
        <city>Campbelltown</city>
        <state>New South Wales</state>
        <zip>2560</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Connie Katelaris, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+61 02 4634 3803</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The Alfred Hospital</name>
      <address>
        <city>Melbourne</city>
        <state>Victoria</state>
        <zip>3004</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Celia M Zubrinich, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+61 3 9076 2239</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Royal Melbourne Hospital</name>
      <address>
        <city>Parkville</city>
        <state>Victoria</state>
        <zip>3050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Charlotte Slade, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+61 393427191</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University of Alberta - Research Transition Facility</name>
      <address>
        <city>Edmonton</city>
        <state>Alberta</state>
        <zip>T6G 2B7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bruce Ritchie, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 780-492-3980</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>McMaster University</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Paul Keith, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 905-525-9140</phone>
      <phone_ext>22851</phone_ext>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Ottawa Allergy Research Corp</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>K1G 6C6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>William Yang, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 418.659.7741</phone>
      <phone_ext>243</phone_ext>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Gordon Sussman Clinical Research</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M3B 3S6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Gordon Sussman, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 4169448333</phone>
      <phone_ext>228</phone_ext>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clinique Spécialisée en Allergie de la Capitale</name>
      <address>
        <city>Québec</city>
        <state>Quebec</state>
        <zip>G1V 4W2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Rémi Gagnon, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+1 418.659.7741</phone>
      <phone_ext>243</phone_ext>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University hospital St. Anna Ustav klinicke imunologie a alergologie, Fakultní nemocnice u sv. Anny v Brně</name>
      <address>
        <city>Brno</city>
        <zip>65691</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Roman Hakl, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+420 5 4318 3131</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>University Hospital Motol</name>
      <address>
        <city>Praha 5</city>
        <zip>150 06</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anna Sediva, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+420 721 141 074</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Markus Magerl, Prof. Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+49 30 450 518 043</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Universitätsklinikum Frankfurt</name>
      <address>
        <city>Frankfurt</city>
        <zip>60590</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emel Aygören-Pürsün, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+49 69-6301-83029</phone>
      <phone_ext>5668</phone_ext>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Johannes Gutenberg-Universität KöR, Hautklinik und Poliklinik der Universitätsmedizin, Clinical Research Center</name>
      <address>
        <city>Mainz</city>
        <zip>55131</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Petra Staubach-Renz, Prof. Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+49 6131-175293</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>HZRM Haemophilie Zentrum Rhein Main GmbH</name>
      <address>
        <city>Mörfelden-Walldorf</city>
        <zip>64546</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Inmaculada Martinez-Saguer, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>++49 6105 96 389 54</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>The University of Hong Kong, Queen Mary Hospital</name>
      <address>
        <city>Hong Kong</city>
        <country>Hong Kong</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philip H, Li, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+852-2255-5947</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Semmelweis Egyetem Altalanos Orvostudományi Kar Belgyógyászati és Hematológiai Klinika</name>
      <address>
        <city>Budapest</city>
        <zip>1088</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Henriette Farkas, Prof. Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+36 208250918</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Barzilai University Medical Center</name>
      <address>
        <city>Ashkelon</city>
        <zip>7830604</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Avner Reshef, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+972-50-5044113</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Mie University Hospital</name>
      <address>
        <city>Mie</city>
        <state>Edobashi, Tsu-shi</state>
        <zip>Edobashi, Tsu-shi</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Keiichi Yamanaka, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+81-59-232-1111</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Saitama Medical Center</name>
      <address>
        <city>Saitama</city>
        <state>Kamoda Kawagoe-shi</state>
        <zip>350-8550</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tomoo Fukuda, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+81-49-228-3606</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Clover Hospital</name>
      <address>
        <city>Kanagawa</city>
        <state>Kugenumaishigami, Fujisawa-shi</state>
        <zip>251-0025</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yuzo Suzuki, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+81-70-3845-9261</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>National Hospital Organization Disaster Medical Center</name>
      <address>
        <city>Tokyo</city>
        <state>Midoricho, Tachikawa-shi</state>
        <zip>190-0014</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yoshihiro Sasaki, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+81-42-526-5511</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Local Incorporated Administrative Agency Osaka City Hospital Organization Osaka City General Hospital</name>
      <address>
        <city>Miyakojima-ku</city>
        <state>Osaka-shi</state>
        <zip>534-0021</zip>
        <country>Japan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keiko Yamagami, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+81-80-8576-4923</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Amsterdam UMC, location AMC</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Erik S. Stroes, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+31 20 5666310</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Auckland City Hospital</name>
      <address>
        <city>Grafton</city>
        <state>Auckland</state>
        <zip>1023</zip>
        <country>New Zealand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hilary Longhurst, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+64 9 3757095</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari General de La Vall d'Hebron</name>
      <address>
        <city>Barcelona</city>
        <zip>8035</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Mar Guilarte, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+34 932746169</phone>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Hospital Gregorio Marañón, Servicio de Alergia</name>
      <address>
        <city>Madrid</city>
        <zip>28007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maria L. Baeza Ochoa, Dr.</last_name>
    </contact>
    <contact_backup>
      <last_name>Call Center</last_name>
      <phone>+34 915868267</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Canada</country>
    <country>Czechia</country>
    <country>Germany</country>
    <country>Hong Kong</country>
    <country>Hungary</country>
    <country>Israel</country>
    <country>Japan</country>
    <country>Netherlands</country>
    <country>New Zealand</country>
    <country>Spain</country>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>February 1, 2021</study_first_submitted>
  <study_first_submitted_qc>February 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 4, 2021</study_first_posted>
  <last_update_submitted>November 16, 2021</last_update_submitted>
  <last_update_submitted_qc>November 16, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 17, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Angioedema</mesh_term>
    <mesh_term>Angioedemas, Hereditary</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>CSL will consider requests to share Individual Patient Data (IPD) from systematic review groups or bona-fide researchers. For information on the process and requirements for submitting a voluntary data sharing request for IPD, please contact CSL at clinicaltrials@cslbehring.com.&#xD;
Applicable country specific privacy and other laws and regulations will be considered and may prevent sharing of IPD.&#xD;
If the request is approved and the researcher has executed an appropriate data sharing agreement, IPD that has been appropriately anonymized will be available.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>IPD requests may be submitted to CSL no earlier than 12 months after publication of the results of this study via an article made available on a public website.</ipd_time_frame>
    <ipd_access_criteria>Requests may only be made by systematic review groups or bona-fide researchers whose proposed use of the IPD is non-commercial in nature and has been approved by an internal review committee.&#xD;
An IPD request will not be considered by CSL unless the proposed research question seeks to answer a significant and unknown medical science or patient care question as determined by CSL's internal review committee.&#xD;
The requesting party must execute an appropriate data sharing agreement before IPD will be made available.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

